IgA Vasculitis and IgA Nephropathy: Same Disease?

被引:41
作者
Pillebout, Evangeline [1 ,2 ]
机构
[1] St Louis Hosp, Nephrol Unit, F-75010 Paris, France
[2] INSERM 1149, Ctr Res Inflammat, F-75870 Paris, France
关键词
IgA Vasculitis; IgA Nephropathy; adults; children; presentation; physiopathology; genetics; prognosis; treatment; HENOCH-SCHONLEIN PURPURA; GALACTOSE-DEFICIENT IGA1; IMMUNOGLOBULIN-A NEPHROPATHY; MYCOPHENOLATE-MOFETIL; DOUBLE-BLIND; OXFORD CLASSIFICATION; CONTROLLED-TRIAL; CLINICAL-OUTCOMES; SERUM-LEVELS; NEPHRITIS;
D O I
10.3390/jcm10112310
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Many authors suggested that IgA Vasculitis (IgAV) and IgA Nephropathy (IgAN) would be two clinical manifestations of the same disease; in particular, that IgAV would be the systemic form of the IgAN. A limited number of studies have included sufficient children or adults with IgAN or IgAV (with or without nephropathy) and followed long enough to conclude on differences or similarities in terms of clinical, biological or histological presentation, physiopathology, genetics or prognosis. All therapeutic trials available on IgAN excluded patients with vasculitis. IgAV and IgAN could represent different extremities of a continuous spectrum of the same disease. Due to skin rash, patients with IgAV are diagnosed precociously. Conversely, because of the absence of any clinical signs, a renal biopsy is practiced for patients with an IgAN to confirm nephropathy at any time of the evolution of the disease, which could explain the frequent chronic lesions at diagnosis. Nevertheless, the question that remains unsolved is why do patients with IgAN not have skin lesions and some patients with IgAV not have nephropathy? Larger clinical studies are needed, including both diseases, with a common histological classification, and stratified on age and genetic background to assess renal prognosis and therapeutic strategies.
引用
收藏
页数:14
相关论文
共 98 条
[1]   Abnormal IgA glycosylation in Henoch-Schonlein purpura restricted to patients with clinical nephritis [J].
Allen, AC ;
Willis, FR ;
Beattie, TJ ;
Feehally, J .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (04) :930-934
[2]   EVOLUTION OF IMMUNOGLOBULIN-A NEPHROPATHY INTO HENOCH-SCHONLEIN PURPURA IN AN ADULT PATIENT [J].
ARAQUE, A ;
SANCHEZ, R ;
ALAMO, C ;
TORRES, N ;
PRAGA, M .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 25 (02) :340-342
[3]   Characteristics and Management of IgA Vasculitis (Henoch-Schonlein) in Adults Data From 260 Patients Included in a French Multicenter Retrospective Survey [J].
Audemard-Verger, Alexandra ;
Terrier, Benjamin ;
Dechartres, Agnes ;
Chanal, Johan ;
Amoura, Zahir ;
Le Gouellec, Noemie ;
Cacoub, Patrice ;
Jourde-Chiche, Noemie ;
Urbanski, Geoffrey ;
Augusto, Jean-Francois ;
Moulis, Guillaume ;
Raffray, Loic ;
Deroux, Alban ;
Hummel, Aurelie ;
Lioger, Bertrand ;
Catroux, Melanie ;
Faguer, Stanislas ;
Goutte, Julie ;
Martis, Nihal ;
Maurier, Francois ;
Riviere, Etienne ;
Sanges, Sebastien ;
Baldolli, Aurelie ;
Costedoat-Chalumeau, Nathalie ;
Roriz, Melanie ;
Puechal, Xavier ;
Andre, Marc ;
Lavigne, Christian ;
Bienvenu, Boris ;
Mekinian, Arsene ;
Zagdoun, Elie ;
Girard, Charlotte ;
Berezne, Alice ;
Guillevin, Loic ;
Thervet, Eric ;
Pillebout, Evangeline .
ARTHRITIS & RHEUMATOLOGY, 2017, 69 (09) :1862-1870
[4]   THE CLINICAL COURSE OF IGA-NEPHROPATHY AND HENOCH-SCHONLEIN PURPURA FOLLOWING RENAL-TRANSPLANTATION [J].
BACHMAN, U ;
BIAVA, C ;
AMEND, W ;
FEDUSKA, N ;
MELZER, J ;
SALVATIERRA, O ;
VINCENTI, F .
TRANSPLANTATION, 1986, 42 (05) :511-515
[5]   Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort [J].
Berthelot, Laureline ;
Jamin, Agnes ;
Viglietti, Denis ;
Chemouny, Jonathan M. ;
Ayari, Hamza ;
Pierre, Melissa ;
Housset, Pierre ;
Sauvaget, Virginia ;
Hurtado-Nedelec, Margarita ;
Vrtovsnik, Francois ;
Daugas, Eric ;
Monteiro, Renato C. ;
Pillebout, Evangeline .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 (09) :1579-1590
[6]  
Calvo-Río V, 2013, CLIN EXP RHEUMATOL, V31, pS45
[7]   Immunological Pattern in IgA Nephropathy [J].
Cols, Clara Esteve ;
Graterol Torres, Freddzia-Amanda ;
Quirant Sanchez, Bibiana ;
Marco Rusinol, Helena ;
Navarro Diaz, Maruja Isabel ;
Ara del Rey, Jordi ;
Martinez Caceres, Eva Ma .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (04)
[8]   IgACE:: A placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria [J].
Coppo, Rosanna ;
Peruzzi, Licia ;
Amore, Alessandro ;
Piccoli, Antonio ;
Cochat, Pierre ;
Stone, Rosario ;
Kirschstein, Martin ;
Linne, Tommy .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (06) :1880-1888
[9]   Pediatric IgA Nephropathy in Europe [J].
Coppo, Rosanna .
KIDNEY DISEASES, 2019, 5 (03) :182-188
[10]   Henoch-Schonlein Purpura Nephritis: Pathophysiology, Treatment, and Future Strategy [J].
Davin, Jean-Claude .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (03) :679-689